Kessler Investment Group’s Zomedica Corp. ZOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-340
Closed -$41 223
2024
Q4
$41 Hold
340
﹤0.01% 184
2024
Q3
$47 Hold
340
﹤0.01% 187
2024
Q2
$50 Hold
340
﹤0.01% 193
2024
Q1
$50 Hold
340
﹤0.01% 188
2023
Q4
$68 Hold
340
﹤0.01% 164
2023
Q3
$57 Hold
340
﹤0.01% 160
2023
Q2
$68 Hold
340
﹤0.01% 169
2023
Q1
$72 Hold
340
﹤0.01% 176
2022
Q4
$0 Hold
340
﹤0.01% 200
2022
Q3
$0 Hold
340
﹤0.01% 196
2022
Q2
$0 Hold
340
﹤0.01% 196
2022
Q1
$0 Sell
340
-15,835
-98% -$5.18K ﹤0.01% 209
2021
Q4
$5K Sell
16,175
-34,992
-68% -$15.8K ﹤0.01% 151
2021
Q3
$27K Sell
51,167
-35,235
-41% -$20.8K 0.02% 114
2021
Q2
$72K Sell
86,402
-25,323
-23% -$23.6K 0.06% 71
2021
Q1
$177K Buy
+111,725
New +$183K 0.23% 35

Other funds holding ZOM

Kessler Investment Group's ZOM Position: Q1 2025 in Review

Kessler Investment Group sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 340 shares — an estimated $41 sold.

Kessler Investment Group first reported a position in ZOM in Q1 2021 and held it in 16 quarters. The position peaked at $177K in Q1 2021. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • Kessler Investment Group reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • Kessler Investment Group sold 340 Zomedica Corp. shares in Q1 2025, an estimated $41.
  • Kessler Investment Group first reported a position in Zomedica Corp. in Q1 2021 and held it in 16 quarters.
  • Kessler Investment Group's Zomedica Corp. position peaked at $177K in Q1 2021.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on Kessler Investment Group's 13F filing for Q1 2025, filed 24 Apr 2025.